Emerging role of heme and heme degradation products in the modulation of cardiac ion channels

NIH RePORTER · NIH · SC2 · $148,000 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY/ABSTRACT Over the past years, research from around the globe has focused on the consumption of red meat and the risk of cardiovascular disease. This positive correlation has been linked to excess heme and its degradation product iron (Fe2+), which are abundant in red meat. Heme serves as a stable cofactor consisting of an iron (Fe2+) coordinated to a porphyrin-IX, often conferring gas sensitivity as exemplified in cytochromes, hemoglobin, myoglobin, and soluble guanylyl cyclase. Excess heme in the system is catabolized by heme oxygenase, which produces carbon monoxide (CO), iron and biliverdin. Emerging evidence, however, suggests a new paradigm of the heme function; intracellular free heme can act as a potent non-genomic acute signaling molecule capable of directly regulating ion channel proteins. Despite the probable physiological and pathophysiological role of heme and other hemp-derived molecules, our knowledge of the acute targets/effectors of heme signaling in the cardiovascular system is severely limited. The goal of this proposal is to define the impacts of heme and heme degradation products (CO) on cardiovascular function by addressing the following questions 1) How do heme and CO impact cardiac ion channels? 2) Does excess heme and CO alter mitophagy in cardiac cells?

Key facts

NIH application ID
10493086
Project number
5SC2GM139715-02
Recipient
UNIVERSITY OF TEXAS RIO GRANDE VALLEY
Principal Investigator
Nirakar Sahoo
Activity code
SC2
Funding institute
NIH
Fiscal year
2022
Award amount
$148,000
Award type
5
Project period
2021-09-23 → 2024-07-31